Cite
Thrombogenicity of sirolimus-eluting stents and bare metal stents: evaluation in the early phase after stent implantation.
MLA
Walter, Thomas, et al. “Thrombogenicity of Sirolimus-Eluting Stents and Bare Metal Stents: Evaluation in the Early Phase after Stent Implantation.” In Vivo (Athens, Greece), vol. 24, no. 5, Sept. 2010, pp. 635–39. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=20952726&authtype=sso&custid=ns315887.
APA
Walter, T., Rey, K. S., Wendel, H. P., Szabo, S., Suselbeck, T., Dempfle, C.-E., Borggrefe, M., Swoboda, S., Beyer, M. E., & Hoffmeister, H. M. (2010). Thrombogenicity of sirolimus-eluting stents and bare metal stents: evaluation in the early phase after stent implantation. In Vivo (Athens, Greece), 24(5), 635–639.
Chicago
Walter, Thomas, Katja S Rey, Hans Peter Wendel, Sebastian Szabo, Tim Suselbeck, Carl-Erik Dempfle, Martin Borggrefe, Stefanie Swoboda, Martin E Beyer, and Hans Martin Hoffmeister. 2010. “Thrombogenicity of Sirolimus-Eluting Stents and Bare Metal Stents: Evaluation in the Early Phase after Stent Implantation.” In Vivo (Athens, Greece) 24 (5): 635–39. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=20952726&authtype=sso&custid=ns315887.